Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TiPY: Testosterone treatment in puberty for boys with Klinefelter syndrome
2023-505854-16-00Phase 4Authorised
- Sponsor
- Rigshospitalet
- Start
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Klinefelter syndrome (KS) comparing AndroGel 1% transdermal testosterone with Placebo transdermal gel (2 arms). Primary endpoint: Change in body composition. Planned start Sep 2023; status: authorised.
02
Drugs
AndroForte
03
Conditions
Klinefelter syndrome (KS)
Beyond the preview
Go deeper on 2023-505854-16-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-505854-16-00.